Over the past year, CLCS returned +29.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +6.0% |
| 1 year | +29.3% |
| 5 years | -65.5% |
| 10 years | -64.7% |
| All-time high | $2.00 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLCS would be worth today ›No. Cell Source, Inc. has not paid a dividend in the past 12 months.
Cell Source, Inc. is part of the Healthcare sector.
Cell Source, Inc. has a market cap of 36.01M USD, based on the latest quote.
